全文获取类型
收费全文 | 26227篇 |
免费 | 2673篇 |
国内免费 | 1881篇 |
专业分类
耳鼻咽喉 | 167篇 |
儿科学 | 350篇 |
妇产科学 | 376篇 |
基础医学 | 3235篇 |
口腔科学 | 478篇 |
临床医学 | 3519篇 |
内科学 | 4168篇 |
皮肤病学 | 241篇 |
神经病学 | 1552篇 |
特种医学 | 967篇 |
外国民族医学 | 21篇 |
外科学 | 2640篇 |
综合类 | 4106篇 |
现状与发展 | 5篇 |
一般理论 | 1篇 |
预防医学 | 1899篇 |
眼科学 | 643篇 |
药学 | 2724篇 |
23篇 | |
中国医学 | 1405篇 |
肿瘤学 | 2261篇 |
出版年
2024年 | 67篇 |
2023年 | 444篇 |
2022年 | 773篇 |
2021年 | 1497篇 |
2020年 | 1103篇 |
2019年 | 963篇 |
2018年 | 1010篇 |
2017年 | 935篇 |
2016年 | 829篇 |
2015年 | 1258篇 |
2014年 | 1472篇 |
2013年 | 1352篇 |
2012年 | 1975篇 |
2011年 | 2174篇 |
2010年 | 1249篇 |
2009年 | 986篇 |
2008年 | 1369篇 |
2007年 | 1283篇 |
2006年 | 1287篇 |
2005年 | 1286篇 |
2004年 | 896篇 |
2003年 | 720篇 |
2002年 | 698篇 |
2001年 | 566篇 |
2000年 | 610篇 |
1999年 | 696篇 |
1998年 | 423篇 |
1997年 | 405篇 |
1996年 | 313篇 |
1995年 | 282篇 |
1994年 | 211篇 |
1993年 | 162篇 |
1992年 | 225篇 |
1991年 | 185篇 |
1990年 | 156篇 |
1989年 | 160篇 |
1988年 | 138篇 |
1987年 | 126篇 |
1986年 | 112篇 |
1985年 | 101篇 |
1984年 | 51篇 |
1983年 | 34篇 |
1982年 | 23篇 |
1981年 | 22篇 |
1980年 | 17篇 |
1979年 | 18篇 |
1978年 | 13篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1971年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Sung-Ching Pan Szu-Min Hsieh Chien-Ching Hung Pei-Fong Huang Mao-Yuan Chen Shan-Chwen Chang 《Journal of microbiology, immunology, and infection》2005,38(1):31-34
This study evaluated the feasibility of reducing the indinavir (IDV) dosage in Taiwanese patients receiving the standard IDV/ritonavir (RTV) dosage of 800/100 mg twice a day who had undetectable plasma human immunodeficiency virus type 1 (HIV-1) RNA but had developed IDV-related toxicities. After dosage reduction to IDV/RTV 600/100 mg twice a day, the dose-related toxicity decreased and plasma HIV RNA remained undetectable at 24 weeks post-switch in all patients. The maximal plasma concentration (Cmax) and area under the plasma concentration-time curve of IDV decreased significantly (median, 6.3 vs 4.3 microg/mL and 1892 vs 1292 microg.min/mL, p=0.01 and 0.001, respectively) but the minimal plasma concentration remained at a similar level (median, 1.0 vs 0.8 microg/mL, p=0.12). This study found that the reduction in the dosage of IDV in HIV-1 infected patients receiving the standard IDV/RTV regimen guided by therapeutic drug monitoring decreased the Cmax, dose-related toxicity and medical cost without compromising viral control. 相似文献
43.
Chunjiang Tan Yuguang Li Xuerui Tan Hongxin Pan Wen Huang 《Clinical chemistry and laboratory medicine》2006,44(10):1218-1225
BACKGROUND: The ubiquitin-proteasome system (UPS) is thought to be functionally active in atherosclerosis (AS) lesions. Aspirin was found to be a potent inhibitor of the UPS in some tumour studies; however, its effect on AS remains to be demonstrated in vivo. METHODS: New Zealand rabbits were placed on a normal diet (N) or on a normal diet with aspirin (NI) or on an atherogenic diet without (H) or with aspirin (HI) for 12 weeks. Proteasome activity, concentrations of plasma lipids and levels of peroxidation were determined. Ubiquitin/ubiquitin-conjugates (Ub), IkappaBalpha, phosphorylated IkappaB (pIkappaBalpha) and p65 were investigated by Western blotting or immunochemistry. RESULTS: Concentrations of plasma lipids and peroxidation levels were higher in H or HI vs. N or NI. Histological analysis showed that atheroma was increased in H. Ub and IkappaBalpha were mainly localised in subendothelium and media vascular smooth muscle cells. Western blots revealed that Ub, IkappaBalpha, and pIkappaBalpha were increased, whereas p65 was lower in HI vs. H. The activity of the 20S proteasome was functionally active in H vs. N, NI or HI, while the 26S proteasome was not affected in any of the groups. CONCLUSIONS: Aspirin can attenuate the pathogenesis of atheroma formation, the degradation of IkappaBalpha and pIkappaBalpha, and lower the expression of p65, indicating that its therapeutic effects on AS may be via inhibition of the UPS. 相似文献
44.
45.
支架内血栓形成是支架置入术后的一种常见并发症。术后血管内皮损伤、胶原组织暴露和作为异物的支架均为引发血栓形成的可能机制。不能及时识别处理则成为再狭窄的重要原因。我们报告1例发生在大脑中动脉(middle cerebral artery,MCA)支架内的血栓形成,探讨其识别处理过程和可能的机制。 相似文献
46.
通心络胶囊对冠状动脉扩张症的治疗价值 总被引:1,自引:1,他引:0
目的评价通心络胶囊对冠状动脉扩张症(CE)患者的治疗效果。方法将38例冠状动脉造影证实为冠状动脉扩张症的心绞痛患者随机分为硝酸异山梨酯和通心络两组,疗程6个月,观察对心绞痛发作及运动平板试验的影响。结果治疗后,通心络组总有效率90.0%,硝酸异山梨酯组总有效率33.3%,两组比较差异显著(P<0.05)。结论通心络胶囊在冠状动脉扩张症患者的治疗中可以明显缓解心绞痛,改善运动平板试验结果,是治疗冠状动脉扩张症患者的有效药物。 相似文献
47.
腹腔镜与开腹直肠癌低位前切除术后吻合口瘘发生率的比较 总被引:4,自引:0,他引:4
目的探讨腹腔镜与开腹直肠癌低位前切除术后吻合口瘘发生率的差异。方法2000年9月至2005年12月由同一组医师连续对距肛缘5~8cm的直肠癌患者实施腹腔镜下根治术(LP术组)53例及传统开腹根治术135例,比较两组和两组内患者造口与未造口者发生吻合口瘘的差异。结果LP术组造口与未造口者吻合口瘘的发生率分别为4.6%(1/22)与6.5%(2/31),χ~2=0.088,P>0.05;差异无统计学意义。OP术组造口与未造口者吻合口瘘的发生率分别为2.3% (1/43)与8.7%(8/92),χ~2=1.024,P>0.05;差异无统计学意义。LP术组与OP术组行造口的患者吻合口瘘发生率比较,P=0.455,差异无统计学意义;LP术组与OP术组未行造口者的吻合口瘘发生率比较,P=0.288,差异也无统计学意义。结论腹腔镜行直肠癌低位前切除术与开腹手术相比,不会增加吻合口痿的发生率。 相似文献
48.
目的 探讨肾小球疾病免疫球蛋白、补体水平与免疫病理的相关性.方法 112 例肾小球疾病患者,14 例健康人测定血清免疫球蛋白及补体,112 例肾小球疾病患者,112 例患者行肾活组织病理检查.结果 112 例肾小球疾病患者 IgG 升高 11 例(9.82%),降低 29 例(25.89%),IgA 升高 33 例(29.46%),降低 2 例(1.79%).IgM 升高 7 例(6.25%),降低 3 例(2.68%),三种免疫球蛋白的变化有显著差异(x2=70.587,P=O.000);C3 减低 29 例(25.89%),C4减低 32 例(28.57%),两者比较无显著差异(X2=0.203,P=0.653).免疫荧光阳性率依次为C3(50%)>lgA(49.11%)>IgG(40.18%)>lgM(21.43%)>C4(14.29%)(x2=49.303,P=0.000);免疫荧光 IgA 阳性者血清 lgA 水平较阴性者高(P=0.042),C3、CA阳性者血清 C3、c4 水平较阴性者低(P=0,P=0.007),IgG、IgM 阳性者血清 IgG、lgM 水平与阴性者比较无差异(P=0.136,P=0.383).结论 肾小球疾病存在体液免疫紊乱,测定血清免疫球蛋白、补体及行肾组织免疫病检有助于了解体液免疫状况,估计疾病活动度,判断疗效,但两种检查之间无明显的相关性,可相互补充,不能相互替代. 相似文献
49.
The mechanism of action of systemitically administered(±)-MDMA (3, 4-methylenedioxymethamphetamine) on spontaneously active neurons in the medial prefrontal cortex (mPFc) of chloral hydrate anesthetized rats was examined using standard single unit extracellular recording techniques. Intravenously administered MDMA dose-dependently decreased the firing rates of the majority of mPFc neurons in control rats. In contrast, in rats that were pretreated withp-chlorophenylalanine (PCPA), which depletes the brain serotonin (5-hydroxytryptamine, 5-HT) content by inhibiting tryptophan hydroxylase, the rate-limiting enzyme in the synthesis of 5-HT, MDMA was largely ineffective in inhibiting the firing of mPFc cells. In PCPA-treated animals, the administration of 5-hydroxytryptophan (5-HTP), which presumably restored the brain 5-HT content, but notl-DOPA, reinstated MDMA's inhibitory action in PCPA-treated rats. In rats that were pretreated withα-methyl-p-tyrosine (AMPT), which depletes the brain dopamine (DA) content by inhibiting tyrosine hydroxylase, the rate-limiting enzyme in the synthesis of DA, MDMA inhibited the firing of all of the mPFc cells. MDMA's effect on mPFc neurons was reversed by 5-HT receptor antagonists such as granisetron and metergoline. These results strongly suggest that MDMA exerts its action on mPFc cells indirectly by releasing endogenous 5-HT. 相似文献
50.
放线菌素23-21属放线菌素类抗癌抗生素,由浅黄色链霉菌产生,该菌从中国福州土壤样品中分离得到。采用裸小鼠人鼻咽癌细胞系(CNE-2Z)和人胃癌细胞系(MGc-803)两种移植模型观察了放线菌素23-21的作用。放线菌素23—21 50μg/kg,对CNE-27移植瘤和MGc803移植瘤的抑制率分别为58.4%(P<0.05)和68.7%(P<0.05)。肿瘤生长曲线显示,治疗组肿瘤生长缓慢。电镜检查,治疗组瘤细胞可见核仁分离和微球体形成。提示放线菌素23-21可能有抑制核仁rRNA合成的作用。在有效剂量下,未见重要脏器病理改变。 相似文献